Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

COVID-19 forces healthcare industry to get creative when battling opioid crisis

By Brian Buntz | January 8, 2021

Oxycodone

Oxycodone image courtesy of Wikipedia

The pandemic has worsened the opioid crisis. In the 12-month period ending in May 2020, the U.S. had 81,000 drug overdoses, with synthetic opioids being the main driver of overdose deaths. That’s the highest number on record, according to provisional data from the CDC. And the volume of overdoses in May was 42% higher than in the same month in 2019. 

The crisis is forcing the healthcare system to find novels ways to treat people with opioid use disorder and those at risk for the condition, said Hari Prasad, co-founder and CEO of Yosicare, which has developed a customizable mobile patient intake and registration platform. 

One central way to battle the opioid epidemic is addressing the current mental health crisis. “COVID-19 has tripled the rate of depression in U.S. adults in all demographic groups — 27.8% of adults reported depression symptoms, in contrast with 8.5% before the pandemic,” Prasad said. 

People with depression, like those with chronic pain, are more likely to abuse opioids. By conducting patient screening assessments, healthcare providers can identify patients at risk for opioid addiction. Using AI algorithms, medical systems can identify individuals with the highest risk of opioid use disorder. After that, “they’re able to intervene, and minimize the risk of an opioid overdose,” Prasad said. 

Examples of such assessments include the CAGE questionnaire, which was initially developed to identify potential alcohol problems but can be adapted for opioid and substance abuse. Pain and medication questionnaires and opioid use disorder assessments are other examples of such tools. 

Telehealth has served as a tool to address patients’ healthcare needs who are reluctant or unable to go to an in-person health facility. More than 75% of medical professionals said telehealth enabled them to provide quality care for COVID-19-related complaints, chronic disease management, hospital and emergency department follow-up, mental health problems and other issues, according to the November 2020 Telehealth Impact Physician Survey. 

Another way to address the opioid epidemic is to streamline alternative therapies when possible to address problems like chronic pain. A back brace could help alleviate pain in a patient with a spinal problem, thus eliminating the need to prescribe opioids. The problem in the past is the process of ordering durable medical equipment in healthcare was “broken,” Prasad said. “It took hours to fill out forms for the providers to submit the order for a back brace,” he said. 

COVID-19 has streamlined the process of ordering durable medical equipment. “Now, it’s possible to order durable medical equipment for a patient with a couple of clicks,” Prasad. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Johnson & Johnson.
Johnson & Johnson announces new North Carolina pharma plant
Samsung Biologics GSK Rockville Maryland plant (1)
Samsung Biologics acquires GSK manufacturing site
Fujifilm logo
Chitose, Fujifilm Biosciences partner on biopharma manufacturing
This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE